Home>>Signaling Pathways>> Others>>Pancreatin

Pancreatin

Catalog No.GC32412

Pancreatin is the porcine pancreas extract (PPE) which contains the main pancreatic digestive enzymes.

Products are for research use only. Not for human use. We do not sell to patients.

Pancreatin Chemical Structure

Cas No.: 8049-47-6

Size Price Stock Qty
100mg
$46.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Pancreatin is the porcine pancreas extract (PPE) which contains the main pancreatic digestive enzymes.

Pancreatin is the porcine pancreas extract (PPE) which contains the main pancreatic digestive enzymes. The amount of free fatty acids (FFAs) titrated at pH 6.5 does increase by 120 and 28% for II-LC and IIIA-LC, respectively, when Pancreatin is increased from 150 to 900 USP U/mL, and the total extent of lipolysis increases by 79 and 28% II-LC and IIIA-LC, respectively. By elevating Pancreatin activity from 150 to 900 USPU/mL, the total extent of digestion on average for LC-LBFs increases by 51%, whereas the amount of FFAs detected at pH 6.5 increases by 55% on average. An increase in extent of digestion is also observed with increasing Pancreatin levels[1].

[1]. Sassene P, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels. AAPS J. 2014 Nov;16(6):1344-57.

Reviews

Review for Pancreatin

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Pancreatin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.